In this issue:

- Improper Calculations of Patent Term Adjustment Where Responses Are Timely Filed Under the Next Business Day Rule

- FDA Regulations and the Regulation of Constitutionally Protected Speech

- FDA Releases Global Engagement Report

- Supreme Court Invalidates Personalized Medicine Patents on Grounds They Are Unpatentable Subject Matter Under Patent Act

- Federal Circuit Clarifies the Scope of Intervening Rights

Please see full newsletter below for more information.